IRF2BP2 and metastatic malignant neoplasm in the lymph nodes: IRF2BP2 expression was closely associated with age (P = .036), tumour size (P = .0006), TNM stage (P = .0002), depth of invasion (P = .0002), lymph node metastasis (P = .0008) and vascular invasion (P = .03) (Table 1).